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ABSTRACT 
 
 
Objective: 
To evaluate the morphometric effect of prenatal exposure to phenytoin, phenobarbital and 
carbamazepine on the shape of the maxilla the posterior and overall cranial base.  
 
Material and Methods: 
Sample selection: 
This study is a retrospective analyses of lateral cephalograms of 67 (Phenobarbital =21, 
Phenytoin=21, Carbamazepine=25) children age 6 to 16 who had been exposed prenatally 
to one of these drugs and compared to a control group of 44 unexposed children of the 
same age. 
Cephalometric films were digitized and anatomical landmarks identified by a single 
investigator. Landmarks were chosen to outline the maxilla, the posterior and overall 
cranial base. Morphometric analysis including Procrustes superimposition was used to 
compare the exposed children to the control group. 
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Principal components analysis (PCA) and MANOVA tests were performed to determine 
the differences between the two groups 
Results: 
The superimposed average showed a significant difference between the two groups. 
In the exposed group, the anterior cranial base was vertically shorter.  Glabella was more 
inferior and anterior relative to nasion, and the nasal tip was more superior and posterior. 
Orbitale was more inferior and posterior, suggesting a more posterior articulation with 
maxilla.  The posterior cranial base was vertically taller and sagittally shorter. 
Also in the exposed group, the maxilla was vertically shorter. 
Conclusion:  
These results demonstrate a shorter, retrusive maxilla that articulates more posteriorly with 
a shorter anterior cranial base, confirming the midface hypoplasia of traditional 
anticonvulsant facies. 
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Review of the Literature 
 
 
Epilepsy 
 
 
Epilepsy, is the second most common neurological disorder; it has been treated extensively 
with antiepileptic drugs (AEDs) or anticonvulsants. The teratogenic potential of the 
commonly used AEDs emerged as a major concern among physicians since 1960 when 
these drugs showed a higher frequency of abnormalities in infants prenatally exposed. The 
malformations were associated with the various types of early-used AEDs, (including 
phenytoin (PHT), phenobarbital (PB), carbamazepine (CBZ), valproic acid, phenobarbital, 
and Trimethadione). Many studies were conducted on humans and animals over the past 6 
decades, and the purpose was to examine the necessity for alternative AED products or 
treatment strategies that maximized clinical effectiveness and minimize the risk on the 
offspring. 
The “Fetal hydantoin syndrome” was introduced to characterize the malformations 
associated to the abnormalities seen in prenatally exposed children to AED’s such as cleft 
lip and palate, congenital heart disease, prenatal and postnatal growth deficiency, 
microcephaly, and mental deficiency, with an estimated occurrence rate ranging from 4 to 
14%.1,2,4,7,8,10,14,18 However, it wasn’t clear how many of these abnormalities and the degree 
of severity that were required to make a syndrome. The wide phenotypic variability of the 
hydantoin syndrome has led many clinicians to question its very existence. Hanson and 
Smith initially described a "broad, multi-system pattern of abnormalities" which included 
prenatal and postnatal growth deficiency, developmental and psychomotor delay, impaired 
intellectual performance, craniofacial malformations, and cardiac, genitourinary, and 
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skeletal anomalies.2 Since this initial description of the fetal hydantoin syndrome, many 
clinical studies were made and confirmed the variety of anomalies associated with in utero 
exposure to hydantoins. However, it was hard for clinicians to find a common etiology for 
such a wide expression of phenotypes, especially when it is believed that a teratogen effect 
is associated.  
Besides, it wasn't clear whether the expanded risk of malformations was brought on by 
epilepsy in general or by specific sorts of epilepsy, a hereditary inclination to epilepsy, a 
hereditary contrast in pharmacokinetics and medication attitude, particular medications, or 
lack states in the mother or embryo induced by certain medications. Shapiro et al 
investigated this disorder and presumed that mothers with epilepsy had just a slight increase 
in major anomalies of their exposed babies, independent of the anticonvulsants used.1 It 
wasn't agreed on whether there was a correlation between the maternal disorder itself and 
the occurrence of the abnormalities in the offspring. In any case, it was for the most part 
acknowledged that the association of a seizure issue and anticonvulsant drugs during 
pregnancy expanded the frequency of dysmorphic qualities in the offspring.4,12 
Many etiologic factors for this risk have been implicated: the severeness of seizures during 
pregnancy; the intelligence and socioeconomic status of the exposed child’s parents; the 
type of antiepileptic drugs (AED) taken by the mother during pregnancy; and the mother’s 
genetic predisposition to having seizures .1,10 However, it was difficult to evaluate the role 
of each of these etiologic factors alone. The most common findings in this syndrome have 
been prenatal and postnatal growth deficiency, microcephaly, and mental deficiency.  
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Between the variety of drugs used to treat seizure disorders, teratogenicity was mostly seen 
for Dilantin/phenytoin, Tridione/trimethadione, Depakene/valproic acid, and 
Tegretol/carbamazepine.12 
The Committee on Drugs of the American Academy of Pediatrics in the 1980’s concluded 
that “pregnant woman should only take drugs when it is necessary for her health or the 
well-being of the fetus, because anticonvulsants have proven to cause increased risks to the 
fetus, even when used cautiously”.1  
The teratogenicity of phenytoin, which was shown to be the most toxic, was studied on 
human and animal. Animal studies supplement human clinical studies, since they help  
avoid the difficulty of controlling the nutrition and other environmental factors that might 
modify normal embryonic development.3,4,6  It is possible to design specific experiments 
to examine, in detail, the pathogenesis of the congenital abnormality; this approach has 
vastly improved the understanding of the morphogenetic abnormalities leading to valproic-
acid-induced neural tube defects or phenytoin-induced craniofacial malformations.6  
Finnell et al. used an animal model to analyze the aspects of the “fetal hydantoin syndrome” 
that were difficult to study within the limitations of a human clinical research.3,6  The study 
revealed the dose -related teratogenic effect of diphenylhydantoin on mouse growth 
and the correlation between the increasing maternal plasma of Dilantin (phenytoin) 
concentrations and the risk of congenital malformations among exposed children. 
Further, it showed the existence of genetic susceptibility to particular phenytoin 
induced abnormalities within different inbred mouse strains. In addition, in 
homozygous quaking (qk/qk) mice, the fetal malformations were associated not with 
the presence of a maternal seizure disorder, but with the phenytoin treatment of the 
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disorder. Animal studies also provided data on neurobehavioral development in FHS: 
Phenytoin caused multiple behavioral dysfunction in rat offspring at subteratogenic 
and non-growth retarding doses. These behaviorally teratogenic doses produce 
maternal serum phenytoin concentrations in rats comparable to those found in 
humans. The dysfunction in rats were dose-dependent and exposure-period-
dependent, but not related to nutrition, maternal caring, or seizure disorder. 
Numerous consequences were seen including vestibular dysfunction, hyperactivity 
and deficit in learning and memory.4 
Nevertheless, not enough literature covered the impact of gestational phenytoin exposure 
which weakens the correlation of human and animal research. Significant among these are 
the absence of behavioral assessments of prenatally exposed children, comparable end 
points for human and animal studies, and a literature integrating human and animal studies. 
In addition, the absence of detailed examinations of dosing conditions which take into 
account changing serum levels under various dosing regimens and at different stages of 
pregnancy comparing the effects on humans and animals. Finally to see if a drug is likely 
to be teratogenic in humans it must be tested in humans.6,4 
Another AED drug known as carbamazepine was introduced as an anticonvulsant in the 
United States in 1974. During the 80s and 90s, carbamazepine (CBZ) was widely used for 
its effectiveness for various types of seizures, but there was considerable controversy in 
early reports of its use in pregnancy with non-adverse and adverse fetal effects described. 
However, as in studies with phenytoin (DPH), these reports were not controlled for a 
variety of confounders that may affect pregnancy outcome.8 
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The “carbamazepine syndrome” was characterized by dysmorphic facial features and mild 
mental retardation. Carbamazepine syndrome was not related to the dosage or the presence 
of maternal convulsions during pregnancy. It may depend upon heredofamilial factors. One 
possible factor is decreased activity of the enzyme epoxide hydrolase with resulting 
increased concentrations of carbamazepine epoxide which may be teratogenic. 
Nulman et al. studied the malformations in children prenatally exposed to phenytoin (DPH; 
34 children) and carbamazepine (CBZ; 36 children) each as a monotherapy, and compared 
them prospectively with matched mother-child pairs exposed to nonteratogens. They 
separated the effects of anticonvulsant medications from those of epilepsy by collecting 
groups of untreated epileptics (9 children) and those treated with DPH and CBZ for other 
medical reasons than epilepsy. There was a significant difference between the two groups 
revealing more minor anomalies among children exposed to either drug and among DPH-
treated non-epileptic offspring.8 As expected, they found that epicanthal folds and 
hypertelorism were linked to phenytoin treatment; on the other hand malar hypoplasia and 
micrognathia were more common in offspring of non-treated epileptics. However other 
characteristics such as frontal bossing and higher foreheads associated with malar 
hypoplasia were seen in the untreated epilepsy subjects, as well as with the subjects treated 
by carbamazepine and phenytoin. This suggested that the epilepsy itself and not the drug 
can cause the anomalies.  Other researchers suggested that microcephaly is a common sign 
of AEDs teratogenicity, but its risk has varied among studies from no risk 67 to 25–30%66. 
Jones et al. evaluated the teratogenic effect of carbamazepine by looking at prenatal 
exposure to this drug alone and in combination with other AED (except phenytoin). Their 
results showed minor craniofacial defects in 11% of the cases, fingernail hypoplasia in 
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26%, and of delay in developmental delay in 20%. These observations suggest that 
carbamazepine is a human teratogen.2,7 
Ornoy et al. studied 47 children aged 6 months-6 years who were born to 37 epileptic 
mothers on carbamazepine monotherapy. Six of the 47 children had typical facial features 
of "carbamazepine syndrome”. The average cognitive score of the children was 
significantly lower compared to the control group. There were no differences between the 
two groups in physical growth or in the rate of major anomalies.7  
Careful analysis of available prospective studies of Kelly et al., 1994, suggests that many 
of the minor craniofacial anomalies in children previously considered to be the 
consequence of intrauterine exposure to AEDs may in fact be linked to epilepsy itself and 
may be genetically determined. It is possible that the anticonvulsant medications increase 
the frequency of anomalies that are already genetically predicted. Sulik et al. suggested 
that teratogenic insults during gastrulation could reduce the cell population of the early 
neural plate, so that there are insufficient cells to form a normal size forebrain. Head defects 
are the most severe of a group of abnormalities that include relatively mild facial and 
central nervous system (CNS) anomalies. Ocular hypotelorism, iris colobomas, flat nasal 
bridge and midface hypoplasia can all be induced by damage during gastrulation.8  
Holmes et al. showed that the children of women who had a seizure history but who were 
untreated by AED and didn’t have any tonic-clonic seizures during pregnancy had an 
increased risk of malformations and diminished intelligence.10 
Robert and Guibaud described an association between prenatally exposure to valproic acid 
and the occurrence of spina bifida in their offspring. Twelve cases of spina bifida among 
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60 infants with birth defects were reported.5 Jones et al. also identified eight cases of spina 
bifida in infants whose mothers had taken carbamazepine during pregnancy. 
Another approach to assess teratogenic effects of AEDs was the use of surveillance systems 
of infants with malformations. Information on all malformed infants born between 1990 
and 1996 with maternal first-trimester drug exposure was collected by the international 
clearing house for birth defects and monitoring systems (ICBDMS). Cases were defined as 
infants presenting with a specific malformation, and controls were defined as infants 
presenting with any other birth defect. Among 8005 cases of malformations, 299 infants 
were exposed in utero to AEDs. Of those exposed to mono-therapy, 65 were exposed to 
phenobarbital, 10 to methylphenobarbital, 80 to valproic acid, 46 to carbamazepine, 24 to 
phenytoin, and 16 to other AEDs. Associations were found for spina bifida with valproic 
acid. Infants exposed to phenobarbital and to methylphenobarbital showed an increased 
risk of oral clefts. Cardiac malformations were found to be associated with phenobarbital, 
methyphenobarbital, valproic acid, and carbamazepine. Hypospadias was associated with 
valproic acid. Porencephaly and other specified anomalies of brain, facial anomalies, 
coarctation of aorta, and limb reduction defects were found to be associated valproic acid.11 
Similarly, Holmes et al. studied 128,049 pregnant women who were screened at delivery 
to identify three groups of infants: those exposed to anticonvulsant drugs, those unexposed 
to anticonvulsant drugs but with a maternal history of seizures, and those unexposed to 
anticonvulsant drugs with no maternal history of seizures (control group). The infants were 
examined systematically for the presence of major malformations, signs of hypoplasia of 
the midface and fingers, microcephaly, and small body size.  The combined frequency of 
anticonvulsant embryopathy was higher in 223 infants exposed to one anticonvulsant drug 
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than in 508 control infants (20.6% vs. 8.5%). The frequency was also higher in 93 infants 
exposed to two or more anticonvulsant drugs than in the controls (28.0% vs. 8.5%). The 
98 infants whose mothers had a history of epilepsy but took no anticonvulsant drugs during 
the pregnancy did not have a higher frequency of those abnormalities than the control 
infants.12 
Kozer et al. conducted a meta-analysis, using a random effects model, of all cohort and 
case-control studies reporting malformation rates in children of women with epilepsy 
exposed or unexposed to antiepileptic drugs compared with that of children of nonepileptic 
women. Medline (1966–2001), EMBASE, the Cochrane database as well as REPROTOX 
(an information system on environmental hazards to human reproduction and 
development) databases were screened.15 They concluded that the risk for congenital 
malformations in the offspring of women with untreated epilepsy was not higher than 
among nonepileptic controls and the offspring of epileptic women who received 
antiepileptic drugs had higher incidences of malformation than controls, thus showing that 
epilepsy itself is not teratogenic. 
Pregnancy registries are another method for assessing the fetal risks from exposures in 
pregnancy. The protocol for AED Pregnancy Registry was developed during several bi-
annual meetings by a committee of neurologists-epileptologists, epidemiologists, birth 
defect specialists, and teratologists with financial support from several companies that 
manufacture and market AEDs. The speed with which information is obtained is a 
significant justification for a pregnancy registry. Holmes et al. presented the findings of the 
North American AED Pregnancy Registry, over 6 years (1997-2002), for phenobarbital 
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sodium exposures. This hospital based pregnancy registry proved that the fetal risk of 
major malformations is increased with phenobarbital sodium.16 
Among the malformations caused by AEDs, some physicians focused on the craniofacial 
features which included a depressed or broadened bridge of the nose, a short nose with 
anteverted nostrils, a long upper lip, and ⁄ or midface hypoplasia. The potential clinical 
significance was suggested by the fact that the anticonvulsant-exposed children with the 
anticonvulsant face had a significant deficit in intellectual function in comparison with the 
anticonvulsant-exposed children without these craniofacial changes.14,18 This hypothesis 
was tested by Holmes et al. who followed up 80 children exposed to anticonvulsant drugs, 
testing cognitive function and a physical examination for head size, height, and the 
presence of midface and digit hypoplasia.18 Microcephaly, midface and digit hypoplasia, 
and major malformations were correlated with full scale (FSI), performance (PIQ) and 
verbal (VIQ) intelligence. The presence of the 3 anticonvulsant-exposed children with 
microcephaly had a deficit of 23.7 IQ points in FSI in comparison with the other children 
with a normal head size. Either midface or digit hypoplasia, correlated significantly with 
deficits in VIQ, PIQ and FSI IQ points. There was no decrease in IQ in association with 
major malformations. They concluded that the presence of midface and digit hypoplasia in 
a child exposed to anticonvulsant drugs in pregnancy is an indication for a systematic 
developmental evaluation.18 Other studies confirmed these effects of commonly used 
antiepileptic drugs on cognitive outcomes in children.19,21  
The analysis of cephalometric radiographs of nine individuals exposed in utero to 
phenytoin and phenobarbital by Van Lang et al. showed that some, but not all, had a 
decreased length of the cranial base, the maxilla, the nasal cartilage, and the bony 
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interorbital distance. Similar deviations had been reported by Lorente and her associates in 
fetal rats exposed to phenytoin (1000 mg ⁄ kg maternal weight) by intra-amniotic injection 
on days 9, 11, and 13 of gestation.14 
Data on all Swedish singleton births between 1995 and 2005, over 900,000 births, were 
obtained from the Swedish Medical Birth Registry to study the effect of AED exposure on 
head circumference in the newborn.20 A significant reduction of mean birth-weight-
adjusted mean head circumference (bw-adj-HC) was seen after both carbamazepine (CBZ) 
and valproic acid (VPA) in monotherapy. No effect on mean bw-adj-HC was seen for 
phenytoin, clonazepam, lamotrigine and gabapentin. There was a significant increase in 
the occurrence of microcephaly (bw-adj-HC smaller than 2 SD below the mean) after any 
AED polytherapy.  
Holmes et al. used cephalometric, hand-wrist, and panoramic radiographs to identify and 
quantify the craniofacial effects from prenatal exposure to phenytoin monotherapy and 
polytherapy and to determine if such deviations persist with age. They evaluated the 
craniofacial structures of 28 anticonvulsant-exposed individuals using 20 landmarks in 
lateral cephalometric radiographs and 19 landmarks in frontal cephalometric radiographs. 
Skeletal maturity was assessed using hand-wrist radiographs. Dental maturity and the 
presence of dental anomalies were evaluated using panoramic radiographs. Eleven 
individuals were re-evaluated 7 years later, on average, to determine the persistence of any 
measured deviations.14 
The evaluated dimensions included linear, angular, and proportional measures. The most 
common deviations were decreased height and length of the maxilla, decreased length of 
the posterior cranial base, length of the mandible, cranial width and level of the cribriform 
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plate, and a decrease in the Wits Appraisal assessment. In addition, a hyperdivergent 
skeletal pattern, steep occlusal plane, and increased nasal bone angle were evident. The 
deviations were more significant in the polytherapy-exposed individuals than in the 
monotherapy exposed individuals. Reevaluation of the 11 individuals revealed that these 
deviations persisted with age, especially in the maxilla. The analysis indicated that several 
skeletal deviations became more pronounced with age. Specifically, the degree of 
maxillary retrognathia in relation to the anterior cranial base increased, the effective 
maxillary length decreased, and the degree of mandibular retrognathia in relation to the 
anterior cranial base decreased. These craniofacial skeletal findings suggest a mild pattern 
of maxillary hypoplasia that becomes more pronounced with age. 
Each anticonvulsant’s unique molecular basis may be associated with specific fetal effects 
and the subsequent expression of unique abnormalities. The underlying molecular defects 
postulated have included a deficiency of the detoxifying enzyme epoxide hydrolase, the 
formation of free radicals, and hypoxia-reperfusion damage resulting from the inhibition 
of potassium channels. The challenge of these hypotheses is to explain why the 
anticonvulsant-exposed fetus develops a specific pattern of abnormalities that includes the 
craniofacial skeletal deviations, digit hypoplasia, cognitive dysfunction, growth 
retardation, and major malformations, which collectively comprise the anticonvulsant 
embryopathy. One potential cellular mechanism is an alteration in the expression of MSX1 
(or HOX7), which is expressed in craniofacial structures and digits. MSX1 has been shown 
to specify one area of mesenchyme that forms the dental field. Mice deficient in MSX1 
present with cleft palates, deficiency of maxillary and mandibular alveolar bones, and ⁄ or 
failure of foot development. A missense mutation in the MSX1 homeodomain was 
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associated with hereditary agenesis of teeth. Polymorphisms of MSX1 have also been 
associated with the occurrence of limb defects. To confirm the relevance of these 
observations, further research is needed to investigate the relationship between in utero 
anticonvulsant exposure and the expression of MSX1.14 
As such, studies since the 1970s have examined the teratogenic effects of the old generation 
of AEDs describing the malformations associated with each type of anticonvulsants. 
Among the various malformations, we aim to focus in this study on the craniofacial 
malformations in order to determine where the associated skeletal changes occur.  
History of Radiographic cephalometry in orthodontics: 
Radiographic cephalometry was introduced in 1931 by Hofrath and Braodbent.22,25,26  At 
first, cephalometric analysis was used for research purposes on facial growth and 
development patterns.  Later, it was added as a clinical tool for evaluating, craniofacial 
growth patterns, dental malocclusions, and to evaluate post- treatment results.   
Prior to lateral cephalometric radiographs, orthodontists could only use casts for diagnosis.  
The latter method only provides information of the inter and intra dental relationships, 
giving no information of the relationship of the jaw bones in relation to each other, the 
cranial base and  in relation to the teeth, and assessment of the soft tissue. 
Cephalometrics helps in understanding the underlying basis for a malocclusion or 
dentofacial deformity.  A cephalometric analysis compares the patient to a reference group, 
so that the patient’s data is compared with norms that are gathered from the patient’s racial 
or ethnic group. 22,27 
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Most cephalometric analyses have been developed for lateral views rather than for the 
frontal views, especially because orthodontists use more lateral cephalograms for pre- and 
post-treatment assessment.25 
Shape, position, orientation, and size of different facial units can be measured using 
cephalometrics, which can be considered applied geometry.23 Each analysis must limit 
these measurements to a small group that would provide the clinician or researcher with 
the most useful information.  Ideally, the measurements should be least affected by size 
and age of the individual. An emphasis on angular measurements has been made to solve 
the former problem and age appropriate tables of standards were created to account for the 
latter. 22 
In 1948 Downs was the first to publish a complete analysis that assessed the relationships 
of the facial bones and its dentition. It was meant to evaluate the cause of facial and dental 
malocclusion.  Downs’s norms were based on variations found in 20 white individuals aged 
between 12-17 years old with “excellent occlusion”.  He used Frankfort horizontal plane 
as a reference plane. 26, 51 However, he realized that this plane does not represent the true 
horizontal and is subject to variations in relation to head position. Later, Moorrees 
suggested the use of natural head position as an extracranial reference plane.  Natural head 
position is “the position the head assumes when a person is standing and his visual axis is 
horizontal.”28 
 In 1953 Steiner was the first to introduce cephalometric analysis that had practical 
applicable in treatment planning.  However, his norm values were based on one Hollywood 
star.  He used sella-nasion as a horizontal reference line.  In establishing his analysis Steiner 
took into consideration teeth, patient’s profile, the maxilla, mandible, and cranial base. 26,29 
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In 1954 Tweed published his analysis that was based on angular measurements between 
Frankfort horizontal plane, mandibular plane and the axial inclination of lower incisor.  He 
believed that normal occlusion goes along with normal facial pattern. Accordingly, he 
selected subjects with normal occlusion, assuming that he was also selecting for facial 
balance and esthetics. 26 
In 1955 Sassouni was the first method to analyze the vertical relationships.  He took into 
consideration the vertical, horizontal and the relationship between the two in defining facial 
type’s deformities. 31 
In 1960 Ricketts used computers to analyze cephalometric measurements. However, he 
derived his norms values for his measurements from an unspecified sample. 22, 30  
In 1974, Harvold analyzed the length of the maxilla and mandible using norms from the 
Burlington growth study. Dissimilarities between the two unit lengths demonstrate jaw size 
discrepancies and the degree of jaw deformity. 22, 26 
In 1983 McNamara presented “the state of the art analysis”.  This analysis uses a nasion-
perpendicular to true horizontal instead of Frankfort horizontal. 32 
Enlow suggested that in addition to individual angular and vertical measurements, the 
clinician must also compare the patient’s proportions with the normal proportions from a 
reference group.33  
Since 1940 no single analysis includes all useful measurements and relationships.  So, the 
best way for the clinician to acquire the needed information is to combine parts of different 
analyses.26 
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Cephalometric analysis, along with clinical analyses, has had a very beneficial effect on 
orthodontic treatment including orthognathic surgery especially in treatment planning and 
in analyzing the effects of these treatments. 22,26 
 
Geometric Morphometrics: 
Aristotle and Plato believed that understanding form led to understanding function. Form 
encompasses size and shape, and finding the line that separates both can be very complex.34 
Previous studies used conventional cephalometric analysis to compare the effects of 
anticonvulsant drugs on the cranial base, maxilla and mandible; however, to be able to 
accurately describe the differences on the growth of the skull and make comparisons 
between the study and control group the use of morphometric analysis might be very 
helpful. 
Morphometrics comes from the Greek ”morphé", meaning 'shape', and ”metría”, meaning 
'measurement’. It refers to the quantitative analysis of form, a concept that encompasses 
size and shape. (Lestrel, 2000). Morphometrics is the application of multivariate statistical 
analysis to the study of shape variation (Reyment, 1985). Bookstein defined morphometrics 
as the study of shape variation and its covariation with other variables (Bookstein, 1991).34, 
35 
Recent advances in geometric morphometric analyses have modified and enhanced the way 
variations in organismic form are measured55, 56. Morphometric analysis is not a recent 
science. It has been used for centuries; however, traditional morphometric data was limited 
to qualitatively describe shapes using measurements of length, depth and width.  These 
measurements give information regarding size, not shape; each is the “…magnitude of a 
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dimension, a measure of size.”57, 38 In the mid-twentieth century geometric morphometrics, 
which is a recent form of morphometrics, shape is defined as “all geometric information 
that remains when location, scale and rotational effects are filtered out from an object.”58,36  
Geometric morphometrics is a landmark based method. The data are coordinates 
of landmarks, which are the discrete anatomical loci that are arguably homologous in all 
individuals in the analysis.57, 40. It is very important to select landmarks in a way that they 
cover a comprehensive sampling of the morphology. Landmarks should be homologous 
and easily found for all the specimens in the study.  Their placement should not alter their 
topological positions relative to other landmarks and they should lie within the same 
plane.57 The landmarks can be two or three dimensional coordinates that record the relative 
positions of anatomically definable points.  
After placing the chosen landmarks, all non-shape data has to be eliminated. Many 
superimposition methods have been proposed including the two-point registration method 
by Bookstein, which standardizes the position of two landmarks by translating the objects 
so one landmark is at origin (0,0), then objects are rotated so that another landmark is at, 
for example, (x,0) in this case.  Then the objects are scaled so that baseline is unity (1, 0). 
Landmark selection for the baseline thus becomes critical, because they may alter the 
results.  41 
Another more suitable approach is the Generalized Procrustes Analysis (GPA).  This 
approach combines rigorous statistical theory for shape, using Kendall’s shape space, with 
analytical procedures for superimposing landmarks to obtain shape variables. 
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Procrustes Superimposition 
 After selecting landmarks, the shapes must be optimally superimposed using a Procrustes 
Superimposition,58 This method is based on using the centroid to superimpose shapes, with 
the centroid being calculated mathematically. Shapes are centered by subtracting 
coordinates of the centroid from each landmarks.  Now each landmark reflects its deviation 
from the centroid. Then landmark configurations are scaled to the centroid size, by dividing 
each coordinates of each landmark by its centroid size. Finally, one landmark is chosen as 
a reference and the others are rotated to minimize partial Procrustes distance.41, 43, 44 
Because scaling is performed, the concept of size is removed.59 
After removing the non-shape variations and generating the shape variables, statistical 
analysis has to be done. Many statistical analyses can be utilized in geometric 
morphometric approach such as TPS, EDMA, FEM/FESA, GPA and PCA.34 However, the 
use of only one technique may not provide all the useful information needed. Therefore, it 
may be advisable to use more than one technique in analyzing the craniofacial form.34 
 
Thin-plate spline analysis (TPS):  
TPS transformation grids can provide a visual description of the shape differences between 
objects.45 One object is transformed/warped into another using the thin plate spline.49 TPS 
has been widely used as the non-rigid transformation model in image alignment and shape 
matching. 
The Thin-plate-spline has a number of properties which have contributed to its popularity: 
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1. It produces smooth surfaces, which are infinitely differentiable. 
2. There are no free parameters that need manual tuning. 
3. It has closed-form solutions for both warping and parameter estimation. 
4. There is a physical explanation for its energy function.34 
 The bending energy will be zero and the plate will be flat if the two shapes are identical.54 
Principle Component Analysis (PCA): 
Principal Component Analysis (PCA), is a morphometric statistical method of shape 
analysis that identifies patterns in data (i.e. landmark location) and expresses them to 
highlight their similarities and differences.24,50,60 
Principle Component Analysis (PCA). The goal is to explain more variations in fewer 
dimensions. Most of the variations in the sample usually can be described with only a few 
PC’s. It is an ordination method that generates scatter plots representing the dispersion of 
shaped in tangent spaces.45 It is the normal regression that is rotated so that the main axis 
of variation (PC1) is horizontal.  Subsequent PC axes are orthogonal to PC1 and are ordered 
to explain sequentially less variations. PCA evaluates the tendency of landmark 
distributions along the x and y-axes, and new principle components are created that 
describe the difference between the landmark configuration and the average shape.  
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Hypothesis and Objectives 
 
 
Hypothesis: Antiepileptic drugs such as phenytoin (PHT), phenobarbital (PB), and 
carbamazepine (CBZ) will have an effect on the shape of the overall cranial base, anterior 
cranial base and maxilla in prenatally-exposed offspring in comparison to the control 
population. 
Specific aim #1: To compare the effect of the effect of prenatal exposure to phenytoin, 
phenobarbital and carbamazepine on the growth of the overall cranial base using 
morphometric analysis. 
Specific aim #2: To compare the effect of the effect of prenatal exposure to phenytoin, 
phenobarbital and carbamazepine on the growth of the maxilla using morphometric 
analysis. 
Specific aim #3: To compare the effect of the effect of prenatal exposure to phenytoin, 
phenobarbital and carbamazepine on the growth of the posterior cranial base using 
morphometric analysis 
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Materials and Methods 
 
 
Sample Selection: 
 
This is a retrospective study using lateral cephalograms of 67 subjects age 6-16 who were 
prenatally exposed to antiepileptic drugs (phenobarbital=21, phenytoin=21, 
carbamazepine=25). Radiographs for the study group were taken from the 
Massachusetts General Hospital Department of Genetics and were de-identified. The 
control group contains 44 children age 6-16 non-exposed prenatally to any kind of 
drugs. Lateral cephalograms for the control group were taken from a previously 
approved repository of cone beam CT scans at the Department of Orthodontics, 
BUGSDM. The approval of the Institutional Review Board (IRB) of the Boston University 
Medical Campus was obtained #H33759. The films for the study group were digitally 
scanned using an Epson Expression 11000XL – Photo Scanner (Epson America, Inc., Long 
Beach, CA) with the settings: Professional Mode, Film, Positive Film, 16-bit Grayscale, 
300 dpi. All films were transformed into TPS files using the program TPS Util.  Films with 
poor contrast, motion blurring, obvious vertical rotation or not of sufficient quality to 
identify the landmarks listed below were excluded.  
 
Inclusion Criteria: 
Sample 
-For the study group all children were prenatally exposed to phenobarbital =21, 
phenytoin=21, carbamazepine=25. 
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-For the control group, the sample was age-matched to each subject in the study group . 
All children were healthy and were not exposed to any medication prenatally. 
-No history of orthodontic treatment 
Quality of films: 
Films had to be of sufficient quality (including contrast and clarity) to identify landmarks 
and trace the cephalogram to be included.  Under- or overexposed films, films containing 
objects that blocked landmarks (e.g. jewelry), or blurry films were excluded from this 
study. 
 
Landmark Selection and Identification: 
The films were digitized and anatomical landmarks identified by a single investigator. 
Landmarks were chosen to outline the posterior cranial base, the maxilla and the overall 
cranial base. Bones were selected based on a previous study using the same sample 
determining the drug effects using traditional cephalometric measurements. 
The landmarks are listed in tables 1, 2, and 3 below.  Semi landmarks were used between 
the landmarks equidistantly. 
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 Table 1. Lateral Cephalogram Landmarks for the Posterior Cranial Base 
Landmark  Definition 
Posterior 
Cranial 
Base 
  
1 Basion (Ba) Lowest point on the anterior border of foramen magnum 
2 Articulare (Ar) 
Intersection of the posterior surface of the mandibular condyle 
and the inferior surface of the posterior cranial base 
3-4  Semi Landmarks equidistantly placed between Ar and Ptms 
5 
Pterygomaxillary 
fissure superior 
(Ptms) 
Most superior point on the outline of the pterygomaxillary 
fissure 
6  Semi landmark between Ptms and Se 
7 
Sphenoethmoidal 
(Se) 
The intersection of the shadow of the great wing of the 
sphenoid and the cranial floor 
8  Semi landmark between Se and Ac 
9 
Anterior clinoid 
process (Ac)  
The tip of the anterior clinoid process  
10 
Tuberculum 
Sella (Ts) 
Most anterior point of Sella turcica 
11 
Floor of Sella 
(Si) 
The lowest point on the internal contour of the sella turcica 
12 
Posterior clinoid 
process (Tc) 
The tip of the posterior clinoid process 
13-14  Semi landmark between Tc and Ba 
 
Table 2.  Lateral Cephalogram Landmarks for the Maxilla 
Landmark  Definition 
Maxilla   
5 
Pterygomaxillary 
fissure superior 
(Ptms) 
Most superior point on the outline of the pterygomaxillary 
fissure 
15-16  Semi landmarks between Ptm and Or 
17 Orbitale (Or) Lowest point of the bony orbit 
18  Semi-landmark between Or and ANS 
19 
Anterior nasal 
spine (ANS) 
The most anterior point on the maxilla at the level of the palate 
20 A point (A) 
The most posterior point on the curvature from the anterior 
nasal spine to the crest of the maxillary alveolar process 
21 Prosthion (Pr) 
The most anterior inferior point of the maxillary anterior 
process  
22 
Upper central 
lingual gingival 
border (U1) 
Lingual cemento-enamel junction of the upper central incisor 
23 
Tip of the distal 
cusp of U6 (U6) 
Most inferior point of the distal cusp of upper first molar  
24 
Posterior nasal 
spine (PNS) 
The most posterior point of the hard palate 
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Table 3. Lateral cephalogram Landmarks for the Overall Cranial Base 
Landmark  Definition 
Overall 
Cranial 
base 
  
1 Basion (Ba) Lowest point on the anterior border of foramen magnum 
2 Articulare (Ar) 
Intersection of the posterior surface of the mandibular condyle 
and the inferior surface of the posterior cranial base 
29 
Pterygomaxillary 
fissure, inferior 
(Ptml) 
Most inferior point on the outline of the pterygomaxillary 
fissure 
5 
Pterygomaxillary 
fissure superior 
(Ptms) 
Most superior point on the outline of the pterygomaxillary 
fissure 
17 Orbitale (Or) Lowest point of the bony orbit 
28 Rhinion (Rh) Tip of the nasal bone 
26 Nasion (N) Most anterior point of the frontonasal suture 
27 Glabella (Gl) Most prominent point on the frontal bone 
25 
Frontomaxillary 
nasal suture 
(Fmn) 
Most superior point of the suture where the maxilla articulates 
with the frontal and nasal bones  
7 
Sphenoethmoidal 
(Se) 
The intersection of the shadow of the great wing of the 
sphenoid and the cranial floor 
9 
Anterior clinoid 
process (Ac) 
The tip of the anterior clinoid process 
10 
Tuberculum 
Sella (Ts) 
Most anterior point of Sella turcica 
11 
Floor of Sella 
(Si) 
The lowest point on the internal contour of the sella turcica 
12 
Posterior clinoid 
process (Tc) 
The tip of the posterior clinoid process 
30 
Bolton point 
(Bo) 
Highest point behind the occipital condyle (Broadbent) 
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  Figure 1: Diagram of landmarks and semi-landmarks 
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Figure 2.  Diagram of the posterior cranial base outline 
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Figure 3.  Diagram of the maxilla  
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Figure 4.  Diagram of the overall cranial base 
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Procrustes Superimposition: 
After exporting the digitized films as .TPS files from TPSDig, the files were imported into 
the computer program “Rstudio” (http://www.rstudio.com/ products/rstudio/). Using the 
package “Geomporph” from the Comprehensive R Archive Network (CRAN), 
geometrically superimposed landmark configurations were produced using the “gpagen” 
function.   Procrustean algorithms first scaled each configuration listed in Table 1, then 
translated to superimpose the centroids and lastly rotated to minimize the squared 
differences between each landmark (semilandmarks were slid along tangent vectors).  This 
is known as the “best-fit” position of the configurations.  The Procrustes mean or the 
consensus configuration (essentially the mean shape of all the landmarks) was calculated.  
The displacement between each landmark and the Procrustes mean (i.e. Procrustes 
distance) was also calculated.   
 
Figure 5.  Example of landmark configuration before Procrustes Superimposition 
(including outlier) 
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Figure 6.  Example of landmark configuration after Procrustes Superimposition (outlier 
removed) 
 
 
Principal Components Analysis: 
The principal components of shape were then analyzed for both the control and study group 
using Rstudio with the package “Geomorph.”.  By utilizing a principal component analysis, 
the shape components from these matrices were computed.  The use of two principal 
components reduces the number of degrees of freedom, while still being representative of 
the shape.  Analysis of the shape data was performed using the “plot-TangentSpace” 
function, and plots showing the variations in shape were produced (Figure 7). 
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Figure 7.  Example of PCA plot depicting difference in mean shape between the control 
(black) and study group (red) for the posterior cranial base 
 
Hypothesis Testing: 
For the hypothesis testing, every facial region (maxilla, posterior and overall cranial base) 
of all the specimens in the study group were superimposed onto the specimens in the 
control group. A representation of the mean tracing of the control and study groups for all 
the facial regions are depicted in Figures 8, 10, 12.  
 
PCA plots for each facial region were created to depict the overall difference in shapes 
between prenatally exposed children to antiepileptic drugs and the control group (Figures 
9, 11, 13). 
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Statistics 
 
MANOVA: 
 
The results of the record analyses were compared between the two groups for the maxilla, 
posterior and overall cranial base using MANOVA, which is a non-parametric multivariate 
hypothesis test of no difference between the groups (MANOVA) The threshold for 
significance was set to? a p-value<0.001,. 
 
Intra-examiner Error: 
The tracings from ten randomly selected films from both group were re-traced and scaled 
in TPSDig two weeks later by the same examiner and the coefficient of reliability was 
determined.  A Pearson Correlation analysis was performed to show the reliability between 
the two readings for all landmarks and intra-examiner error was found to be 92%, 
demonstrating a strong correlation. 
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Results 
 
The superimposed average tracings of both groups revealed that the shape of each region 
in the study group was significantly different from that of the control group. 
Maxilla: 
A principal components analysis for all 11 anatomical landmarks outlining the maxilla and 
all the specimens was performed to reduce the number of dimensions to be able to visualize 
the overall difference in shape of the maxilla between the groups.  As shown in Figure 9, 
each specimen is visualized as a single coordinate, and the distance between the specimens 
depicts the difference in overall shape of the maxilla when the 11 landmarks are 
superimposed (using Procrustes superimposition).  The closer together the specimens’ 
landmarks are to each other in these plots, the more closely they “fit” together and vice 
versa.  A significant difference between the two groups is visualized upon inspection of 
this plot, with a p<0.001 using a multivariate regression model to test for the interaction 
between exposed and non- exposed children (Table 4) 
Figure 8 depicts the difference in the mean shapes between the control and study group 
showing the difference in position between the landmarks. In the exposed group, the 
maxilla was vertically shorter.  Anterior nasal spine was more superior relative to A point, 
posterior nasal spine was more superior and anterior, and orbitale was more inferior and 
posterior.  
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Figure 8.  Average tracing of both control and study group with the vector of difference 
between corresponding landmarks for the maxilla. (Red is the study group) 
 
 
Figure 9.  PCA plot of all 67 prenatally exposed children to anticonvulsant drugs and all 
of 44 non- exposed children with all 11 landmarks outlining the maxilla (Red is the study 
group) 
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Table 4.  Results of MANOVA for the maxilla 
 
           Df SumsOfSqs  MeanSqs F.Model      R2    Pr(>F)     
group2      1   0.07072 0.070722  8.0627 0.06888 9.999e-05 *** 
Residuals 109   0.95609 0.008771         0.93112               
Total     110   1.02681                  1.00000               
 
 
 
Posterior Cranial base: 
A principal component analysis for all 14 anatomical landmarks outlining the posterior cranial 
base was performed to reduce the number of dimensions in order to to visualize the overall 
difference in shape of the posterior cranial base between the groups.  As shown in Figure 10, each 
specimen is visualized as a single coordinate, and the distance between the specimens depicts the 
difference in overall shape of the posterior cranial base when the 14 landmarks are reflected and 
superimposed (using Procrustes superimposition).  The closer together the specimens’ landmarks 
are to each other in these plots, the more closely they “fit” together and vice versa.  A significant 
difference of p<0.001 between the two groups was visualized upon inspection of this plot, using a 
multivariate regression model to test for the interaction between exposed and non- exposed 
children. (Table 5) 
Figure 11 depicts the difference in the mean shapes between the control and study group showing 
the difference in position between the landmarks. In the exposed group, the posterior cranial base 
was vertically taller and sagittally shorter. 
 
35 
 
 
 
 
Figure 10.  Average tracing of both control and study group with the vector of difference 
between corresponding landmarks for the posterior cranial base. (Red is the study group) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11.  PCA plot of all 67 prenatally exposed children to anticonvulsant drugs and all of 44 
non- exposed children with all 14 landmarks outlining the posterior cranial base (Red is the study 
group) 
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Table 5.  Results of MANOVA for the posterior cranial base 
 
Df SumsOfSqs  MeanSqs F.Model      R2    Pr(>F)     
group2      1   0.09626 0.096262  8.2198 0.07012 9.999e-05 *** 
Residuals 109   1.27650 0.011711         0.92988               
Total     110   1.37276                  1.00000               
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
 
Overall cranial base: 
 
A principal components analysis for all 15 anatomical landmarks outlining the overall cranial base 
and all the specimens was performed to reduce the number of dimensions and visualize the overall 
difference in shape of the overall cranial base between the groups.  As shown in Figure 12, each 
specimen is visualized as a single coordinate, and the distance between the specimens depicts the 
difference in shape of the overall cranial base when the 15 landmarks are superimposed (using 
Procrustes superimposition).  The closer together the specimens’ landmarks are to each other in 
these plots, the more closely they “fit” together and vice versa.  A significant difference at the level 
of p<0.001 between the two groups was visualized upon inspection of this plot, using a multivariate 
regression model to test for the interaction between exposed and non- exposed children. (Table 6) 
Figure 13 depicts the difference in the mean shapes between the control and study group showing 
that in the exposed group, the anterior cranial base was vertically shorter.  Glabella was more 
inferior and anterior relative to nasion, and the nasal tip was more superior and posterior. Orbitale 
was more inferior and posterior, suggesting a more posterior articulation with the maxilla. 
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Figure 12.  Average tracing of both control and study group with the vector of difference 
between corresponding landmarks for the overall cranial base. (Red is the study group) 
 
 
Figure 13.  PCA plot of all 67 prenatally exposed children to anticonvulsant drugs and all of 44 
non- exposed children with all 14 landmarks outlining the overall cranial base (Red is the study 
group) 
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Table 6.  Results of MANOVA for the overall cranial base 
 
Df SumsOfSqs  MeanSqs F.Model      R2    Pr(>F)     
group1      1   0.04291 0.042909  8.3383 0.07106 9.999e-05 *** 
Residuals 109   0.56092 0.005146         0.92894               
Total     110   0.60383                  1.00000               
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
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Discussion 
 
 
Extra-oral examinations are not sufficient in determining the subtle changes in the 
craniofacial complex in the exposed children. Therefore a morphometric cephalometric 
analysis of lateral cephalograms can be a very useful adjunct to determine how the 
development of the craniofacial structures such as the maxilla, posterior and overall cranial 
base affected the shape of the skull. 
Using anatomic landmarks instead of orthodontic landmarks, the differences in the overall 
shape of the posterior and overall cranial base in addition to the maxilla could be better 
appreciated. 
 In this study we used the generalized Procrustes superimposition (PS) to superimpose 
shapes of the bones studied.  This method has shown to be optimally superimposing the 
shapes compared to earlier methods used such as Bookstein’s. PS translates, rotates and 
uniformly scales the objects. The aim is to obtain a similar placement and size by 
minimizing a measure of shape difference called the Procrustes distance between the 
objects.52, 62 
For statistics we will need to remove the redundant dimensions created by the Procrustes 
superimposition, and the thin plate spline? has been shown in the literature to be an 
adequate method to use.59 
In the last two decades techniques of morphometric analyses of landmark data have 
developed tremendously.61The thin plate spline analysis (TPS) generates an illustration of 
shape differences and displays more morphological differences as compared to earlier 
methods.50,52 TPS plots the morphological differences between two landmarks 
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configuration as a transformation grid. TPS is frequently used to visualize shape 
differences and this is why we decided to use this method for our research.61 
Finally the data is statistically analyzed using the Principal component analysis (PCA), 
which allows a comprehensive description of the shape. 
 
The result of the morphometric cephalometric analysis in this present study showed 
significantly different results in the shapes of the maxilla, posterior and overall cranial base 
of the exposed group to AED’s. 
 
 
In the exposed group: 
 The anterior cranial base was vertically shorter.   
 Glabella was more inferior and anterior relative to Nasion  
 The nasal tip was more superior and posterior. 
 Orbitale was more inferior and posterior, suggesting a more posterior articulation 
with maxilla.   
 The posterior cranial base was vertically taller and sagittally shorter. 
 The maxilla was vertically shorter.  
 Anterior nasal spine was more superior relative to A point 
 Posterior nasal spine was more superior and anterior 
The shortening of the maxilla and cranial base seen in this study confirms Van Lang et al61 
and Orup et al14 researches that children exposed to the anticonvulsant drugs have 
shortening of the dimensions of the maxilla, cranial base and nasal bone. 
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Previous clinical studies have shown that the prenatal exposure to phenytoin, phenobarbital 
and carbamazepine can also produces major malformations, such as spina bifida, digit 
hypoplasia, and a three-fold increase in the frequency of cleft lip and palate5,64. So, it would 
be predicted that there is an effect on craniofacial bones. 
In this study using cephalometric analysis we showed graphically how the shapes of the 
bones (maxilla, posterior and overall cranial base) were significantly different after 
superimposing them. 
The changes in the maxilla and nasal bones produce shortening of the nose with anteverted 
nostrils and flattening of the maxilla that are characteristics of "the anticonvulsant facies". 
The effect of anticonvulsant drugs on the cranium also suggests an effect on the posterior 
cranial base including the sphenoid bone, which is a major component of the cranial base.  
This is understandable given the central location of the sphenoid bone in the craniofacial 
complex.  
The differences seen in the shapes of the bones in the cranium might perhaps be related to 
a primary insult in the gene formations of the fetus at an early stage in the pregnancy. There 
is not enough evidence in the literature that supports such a hypothesis, but it would be 
interesting to conduct a study that goes back to the genomes of the prenatally exposed 
children and check if a correlation exists.  
As orthodontists, it would be very useful to add a question to our new patient’s medical 
history to know if their mothers were under any kind of antiepileptic drugs during their 
pregnancy. This would help in the treatment planning and maybe if these children are seen 
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at an early enough age, first phase orthodontics using functional appliances could be used 
to help the growth of their maxilla, knowing that it would develop to be retrusive after 
completion of growth if no functional appliances are used. This could also in many cases 
prevent these children from having jaw surgery to correct the discrepancies between their 
mandible and maxilla. 
 
Strengths 
Our study aimed to improve upon these original studies of craniofacial measurements of 
prenatally exposed children to anticonvulsant drugs and included anatomical landmarks, 
which outlined shapes of bones in the cranium including the maxilla, the overall and 
posterior cranial base.  We also used geometric morphometric analyses and removed the 
element of size to look solely at the differences in shape.  By improving the technique of 
comparison, our research revealed significant differences between prenatally exposed 
children to anticonvulsant drugs and the control group. 
Morphometric analysis has shown to be very effective in comparing the shapes of the 
different bones that we looked at in the study. 
Limitations 
Our study utilized lateral cephalograms from a previous research, and it is unknown if the 
same technician took all the films orienting the subjects’ heads the same way. Not 
positioning the patients in an ideal position may be a source of error, especially with the 
known fact of the difficulty of 2D x-rays requiring accurate head position.65 Head position 
orientation errors can cause errors in landmarks positioning. But in our study we used 
geometric morphometric to compare the shapes, which removes all the size factors.  
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Summary and Conclusions 
 
Our results demonstrate a shorter, retrusive maxilla that articulates more posteriorly with a 
shorter anterior cranial base, confirming the midface hypoplasia of traditional 
anticonvulsant facies. 
Physicians should consider the teratogenic potency of these drugs when prescribing them 
to pregnant women.  
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